Salwa Suliman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Salwa Suliman has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Anke Krueger
Institute of Organic Chemistry, University of Würzburg, 97074, Würzburg, Germany
2 shared publicationsJoachim Nickel
Chair Tissue Engineering and Regenerative Medicine, University Hospital of Würzburg, 97070, Würzburg, Germany
2 shared publications- Kamal Mustafa
Department of Clinical Dentistry, Center for Clinical Dental Research, University of Bergen, Norway
2 shared publications Thilo Waag
Institute of Organic Chemistry, University of Würzburg, 97074, Würzburg, Germany
2 shared publicationsTorbjorn O. Pedersen
Department of Clinical Dentistry, Center for Clinical Dental Research, University of Bergen, 5009, Bergen, Norway
2 shared publicationsYang Sun
Department of Fibre and Polymer Technology, KTH, Royal Institute of Technology, 10044, Stockholm, Sweden
2 shared publications
Latest Publications
- Open Access
- 8 February 2016
- Published by Wiley in Advanced Healthcare Materials
- Vol. 5 (6) , 730-742
In Vivo Host Response and Degradation of Copolymer Scaffolds Functionalized with Nanodiamonds and Bone Morphogenetic Protein 2
The aim is to evaluate the effect of modifying poly[(l‐lactide)‐co‐(ε‐caprolactone)] scaffolds (PLCL) with nanodiamonds (nDP) or with nDP+physisorbed BMP‐2 (nDP+BMP‐2) on in vivo host tissue response and degradation. The scaffolds are implanted subcutaneously in Balb/c mice and retrieved after 1, 8, and 27 weeks. Molecular weight analysis shows that modified scaffolds degrade faster than the unmodified. Gene analysis at week 1 shows highest expression of proinflammatory markers around nDP scaffolds; although the presence of inflammatory cells and foreign body giant cells is more prominent around the PLCL. Tissue regeneration markers are highly expressed in the nDP+BMP‐2 scaffolds at week 8. A fibrous capsule is detectable by week 8, thinnest around nDP scaffolds and at week 27 thickest around PLCL scaffolds. mRNA levels of ALP, COL1α2, and ANGPT1 are significantly upregulating in the nDP+BMP‐2 scaffolds at week 1 with ectopic bone seen at week 8. Even when almost 90% of the scaffold is degraded at week 27, nDP are observable at implantation areas without adverse effects. In conclusion, modifying PLCL scaffolds with nDP does not aggravate the host response and physisorbed BMP‐2 delivery attenuates inflammation while lowering the dose of BMP‐2 to a relatively safe and economical level.
- 8 February 2016
- Published by Wiley in Advanced Healthcare Materials
- Vol. 5 (6) , 730-742
Open AccessIn Vivo Host Response and Degradation of Copolymer Scaffolds Functionalized with Nanodiamonds and Bone Morphogenetic Protein 2
The aim is to evaluate the effect of modifying poly[(l‐lactide)‐co‐(ε‐caprolactone)] scaffolds (PLCL) with nanodiamonds (nDP) or with nDP+physisorbed BMP‐2 (nDP+BMP‐2) on in vivo host tissue response and degradation. The scaffolds are implanted subcutaneously in Balb/c mice and retrieved after 1, 8, and 27 weeks. Molecular weight analysis shows that modified scaffolds degrade faster than the unmodified. Gene analysis at week 1 shows highest expression of proinflammatory markers around nDP scaffolds; although the presence of inflammatory cells and foreign body giant cells is more prominent around the PLCL. Tissue regeneration markers are highly expressed in the nDP+BMP‐2 scaffolds at week 8. A fibrous capsule is detectable by week 8, thinnest around nDP scaffolds and at week 27 thickest around PLCL scaffolds. mRNA levels of ALP, COL1α2, and ANGPT1 are significantly upregulating in the nDP+BMP‐2 scaffolds at week 1 with ectopic bone seen at week 8. Even when almost 90% of the scaffold is degraded at week 27, nDP are observable at implantation areas without adverse effects. In conclusion, modifying PLCL scaffolds with nDP does not aggravate the host response and physisorbed BMP‐2 delivery attenuates inflammation while lowering the dose of BMP‐2 to a relatively safe and economical level.
- Open Access
- 1 January 2015
- Published by Elsevier in Journal of Controlled Release
- Vol. 197, 148-157
Release and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo
- 1 January 2015
- Published by Elsevier in Journal of Controlled Release
- Vol. 197, 148-157
Open AccessRelease and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo